CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Raises Price Target on Regeneron Pharmaceuticals to $810 From $737, Keeps Sector Perform Rating

Positive
AI Analysis

Summary

RBC Capital Markets raised its price target on Regeneron Pharmaceuticals to $810 from $737 while maintaining a Sector Perform rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 11:22 AM

Read Original